Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease

Journal of the American Society of Nephrology

Volumn 24, Issue 11, 2013, Pages 1901-1912

  Sharma, Kumar ^a,b,c   Karl, Bethany ^a,c   Mathew, Anna V ^a,c   Gangoiti, Jon A ^d   Wassel, Christina L ^a   Saito, Rintaro ^a,b   Pu, Minya ^a   Sharma, Shoba ^a   You, Young Hyun ^a   Wang, Lin ^a   Diamond Stanic, Maggie ^a,c   Lindenmeyer, Maja T ^e   Forsblom, Carol ^f   Wu, Wei ^a   Ix, Joachim H ^a,c   Ideker, Trey ^b   Kopp, Jeffrey B ^g   Nigam, Sanjay K ^a   Cohen, Clemens D ^h   Groop, Per Henrik ^f,h   Barshop, Bruce A ^a,d   Natarajan, Loki ^a   Nyhan, William L ^a,d   Naviaux, Robert K ^a,b,d   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d Division of Medical Genetics   (United States)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^g NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^h BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 3 HYDROXYPROPIONATE; 2 HYDROXYBUTYRIC ACID; 2 METHYLACETOACETATE; 3 HYDROXY 2 METHYLPROPIONIC ACID; 3 HYDROXYISOVALERIC ACID; 3 METHYLADIPIC ACID; 3 METHYLCROTONYLGLYCINE; 4 HYDROXYHIPPURATE; ACONITIC ACID; BIOCHEMICAL MARKER; CARBOXYLIC ACID; CITRIC ACID; GLYCOLIC ACID; HOMOVANILLIC ACID; HYDRACRYLIC ACID; MITOCHONDRIAL PROTEIN; N ACETYLASPARTIC ACID; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SUCCINIC ACID; TIGLYLGLYCINE; UNCLASSIFIED DRUG; URACIL;

ADULT; ARTICLE; BIOINFORMATICS; CHRONIC KIDNEY DISEASE; CITRIC ACID CYCLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXOSOME; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL RESPIRATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCREENING; URINALYSIS; VALIDATION STUDY;

EID: 84887108045     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013020126     Document Type: Article

References (28)

1. Rosolowsky ET, Skupien J, Smiles A.M., Niewczas M., Roshan B, Stanton R, Eckfeldt J.H., Warram JH, Krolewski AS: Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephro 122: 545-553, 2011
2. Groop PH, Thomas MC, Moran J.L., Wadèn J, Thorn L.M., Mäkinen VP, Rosengård-Bärlund M, Saraheimo M, Hietala K, Heikkilä O., Forsblom C; FinnDiane Study Group: The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58: 1651-1658, 2009
3. Susztak K, Böttinger E, Novetsky A., Liang D, Zhu Y, Ciccone E., Wu D, Dunn S, McCue P., Sharma K: Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 53: 784-794, 2004 (Pubitemid 38270650)
4. Ewens KG, George RA, Sharma K, Ziyadeh F.N., Spielman RS: Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test. Diabetes 54: 3305-3318, 2005 (Pubitemid 43336530)
5. Sharma K, Lee S, Han S., Lee S, Francos B, McCue P., Wassell R, Shaw MA, Ramachandra Rao SP: Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 5: 2648-2655, 2005 (Pubitemid 40966492)
6. Newgard CB, An J, Bain J.R., Muehlbauer MJ, Stevens RD, Lien LF, Haqq A.M., Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D., Ilkayeva O, Wenner BR, Yancy WS Jr, Eisenson H, Musante G, Surwit R.S., Millington DS, Butler MD, Svetkey LP: A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311-326, 2009
7. Wang TJ, Larson MG, Vasan R.S., Cheng S., Rhee EP, McCabe E, Lewis GD, Fox C.S., Jacques PF, Fernandez C, O'Donnell CJ, Carr SA, Mootha V.K., Florez JC, Souza A, Melander O, Clish C.B., Gerszten RE: Metabolite profiles and the risk of developing diabetes. Nat Med 17: 448-453, 2011
8. Sweetman L, Nyhan WL: Detailed comparison of the urinary excretion of purines in a patient with the Lesch-Nyhan syndrome and a control subject. Biochem Med 4: 121-134, 1971
9. Nyhan WL, James JA, Teberg A.J., Sweetman L., Nelson LG: A new disorder of purine metabolism with behavioral manifestations. J Pediatr 74: 20-27, 1969
10. Aramaki S, Lehotay D, Nyhan W.L., MacLeod PM, Sweetman L: Methylcitrate in maternal urine during a pregnancy with a fetus affected with propionic acidaemia. J Inherit Metab Dis 12: 86-88, 1989 (Pubitemid 19095913)
11. Natarajan L, Pu M, Messer K: Exact statistical tests for the intersection of independent lists of genes. Ann Appl Stat 6: 521-541, 2012
12. Nigam SK, Bush KT, Bhatnagar V: Drug and toxicant handling by the OAT organicanion transporters in the kidney and other tissues. Nat Clin Pract Nephrol 3: 443-448, 2007 (Pubitemid 47123587)
13. Eraly SA, Vallon V, Vaughn D.A., Gangoiti JA, Richter K, Nagle M, Monte J.C., Rieg T., Truong DM, Long JM, Barshop BA, Kaler G, Nigam SK: Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice. J Biol Chem 281: 5072-5083, 2006 (Pubitemid 43847773)
14. Ohtsuki S, Kikkawa T, Mori S., Hori S, Takanaga H, Otagiri M., Terasaki T: Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of bloodbrain barrier. J Pharmacol Exp Ther 309: 1273-1281, 2004 (Pubitemid 38669719)
15. Wikoff WR, Nagle MA, Kouznetsova V.L., Tsigelny IF, Nigam SK: Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). J Proteome Res 10: 2842-2851, 2011
16. Kaler G, Truong DM, Khandelwal A, Nagle M., Eraly SA, Swaan PW, Nigam SK: Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members. J Biol Chem 282: 23841-23853, 2007 (Pubitemid 47328029)
17. Zhou H, Cheruvanky A, Hu X., Matsumoto T, Hiramatsu N, Cho M.E., Berger A., Leelahavanichkul A, Doi K, Chawla L.S., Illei GG, Kopp JB, Balow JE, Austin HA 3rd, Yuen PS, Star RA: Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int 74: 613-621, 2008
18. Spiegelman BM: Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Found Symp 287: 60-63, discussion 63-69, 2007
19. Barrès R., Osler ME, Yan J, Rune A., Fritz T, Caidahl K, Krook A., Zierath JR: Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 10: 189-198, 2009
20. van der Kloet FM, Tempels FW, Ismail N, van der Heijden R, Kasper PT, Rojas-Cherto M, van Doorn R, Spijksma G, Koek M, van der Greef J, Mäkinen VP, Forsblom C, Holthöfer H, Groop PH, Reijmers TH, Hankemeier T: Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabolomics 8: 109-119, 2012
21. Ahn SY, Nigam SK: Toward a systems level understanding of organic anion and other multispecific drug transporters: A remote sensing and signaling hypothesis. Mol Pharmacol 76: 481-490, 2009
22. Wu W, Dnyanmote AV, Nigam SK: Remote communication through Slc and Abc drug transporter pathways: an update on the remote sensing and signaling hypothesis. Mol Pharmacol 79: 795-805, 2011
23. Dugan L, You Y-H, Ali S, Diamond-Stanic M, Miyamoto S., DeCleves AE, Andreyev A, Quach T, Ly S., Shekhtman G, Nguyen W, Chepetan A., Le TP, Wang L, Xu M, Paik K.P., Fogo A., Viollet B, Murphy A, Brosius F., Naviaux RK, Sharma K: Reduced superoxide and mitochondrial function in diabetes is AMPK dependent. J Clin Invest, in press, 2013
24. Sharma K, Ix JH, Mathew A.V., Cho M., Pflueger A, Dunn SR, Francos B, Sharma S, Falkner B, McGowan TA, Donohue M, Ramachandrarao S, Xu R, Fervenza F.C., Kopp JB: Pirfenidone for diabetic nephropathy. J Am Soc Nephrol 22: 1144-1151, 2011
25. Hoffmann G, Aramaki S, Blum-Hoffmann E, Nyhan W.L., Sweetman L: Quantitative analysis for organic acids in biological samples: Batch isolation followed by gas chromatographic-mass spectrometric analysis. Clin Chem 35: 587-595, 1989 (Pubitemid 19111072)
26. Cohen CD, Frach K, Schlöndorff D, Kretzler M: Quantitative gene expression analysis inrenal biopsies: Anovel protocol for ahigh-throughput multicenter application. Kidney Int 61: 133-140, 2002 (Pubitemid 34075139)
27. Schmid H, Boucherot A, Yasuda Y., Henger A, Brunner B, Eichinger F., Nitsche A, Kiss E, Bleich M., Gröne HJ, Nelson P.J., Schlöndorff D, Cohen C.D., Kretzler M; European Renal cDNA Bank (ERCB) Consortium: Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55: 2993-3003, 2006 (Pubitemid 44923635)
28. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Royal Stat Soc, Series B (Methodological) 57: 289-300, 1995